Physician profile
Daniel Andreas Ratliff
NPI 1336303122
$17,991.24
in general payments reported to CMS, 2019-2025
42 companies · $2,636 in 2025
The $2,636 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,225 · 2020: $1,329 · 2021: $2,501 · 2022: $2,996 · 2023: $2,991 · 2024: $2,313 · 2025: $2,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,939.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,583.86 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $2,067.38 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Watchman Access System |
| Medtronic Vascular, INC. | $1,513.83 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $1,304.00 | 2019-2024 | Xarelto |
| Pfizer INC. | $1,109.24 | 2021-2025 | |
| Edwards Lifesciences Corporation | $1,005.02 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $806.09 | 2019-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $765.38 | 2021-2025 | Lifevest |
| Abbott Laboratories | $694.10 | 2019-2024 | Navitor, Mitraclip, Diamondback Peripheral |
| Amgen INC. | $679.41 | 2019-2024 | Repatha |
| Shockwave Medical, INC | $632.56 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $459.23 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $452.94 | 2021-2025 | Camzyos, Eliquis |
| Cardinal Health 200 LLC | $343.87 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $333.91 | 2019-2025 | Brilinta, Lokelma, Farxiga |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $313.56 | 2023-2025 | Brite Tip Radianz, Mynx Venous Vcd, Mynx Control Venous |
| Siemens Medical Solutions USA, INC. | $186.39 | 2020 | |
| Cardiovascular Systems INC. | $150.48 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $141.37 | 2019-2024 | |
| Bard Peripheral Vascular, INC. | $140.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.84 | 2021-2024 | Jardiance |
| W. L. Gore & Associates, INC. | $124.60 | 2024 | Gore Cardioform Septal Occluder |
| Mallinckrodt Enterprises LLC | $114.60 | 2019 | |
| Merck Sharp & Dohme LLC | $101.05 | 2021-2023 | Verquvo |
| Biotronik INC. | $99.43 | 2022 | |
| Alnylam Pharmaceuticals INC. | $92.50 | 2021-2024 | Onpattro |
| Terumo Medical Corporation | $92.24 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $79.68 | 2019-2024 | |
| Philips North America LLC | $65.39 | 2019 | |
| Scpharmaceuticals INC. | $62.64 | 2025 | |
| Biosense Webster, INC. | $58.29 | 2021-2025 | Carto 3 |
| Esperion Therapeutics, INC. | $52.88 | 2021-2024 | Nexletol |
| Teleflex LLC | $47.69 | 2023-2025 | Guideliner |
| Angiodynamics, INC. | $27.61 | 2023 | Alphavac |
| Heartflow, INC. | $25.32 | 2023 | Ffrct |
| Novo Nordisk INC | $24.97 | 2024 | Wegovy |
| Atricure, INC. | $23.96 | 2022 | |
| Akcea Therapeutics, INC. | $21.51 | 2021 | |
| Sanofi Pasteur INC. | $17.28 | 2019 | |
| Amarin Pharma, INC. | $14.65 | 2019 | |
| Chiesi USA, INC. | $11.98 | 2019 | |
| Lilly USA, LLC | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ratliff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.